APAC Vaccines Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5005

  • Format: PPT, PDF

APAC Vaccines Market Analysis: Segmented by Application, Disorders, Devices & Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear

Report Description of the APAC Vaccines Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Vaccines Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Vaccines Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Vaccines Market Analysis Executive Summary

Vaccines are product that work with the body’s immune system to protect against dangerous infections, lowering the chance of contracting a disease. Vaccines for life threatening infections have been developed preventing around 2-3 million fatalities each year from disease such as tetanus, diphtheria, pertussis, measles, and influenza.

Market Size and Key Findings

The APAC Vaccines Market Analysis size stood at around USD 7.25 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 6.4% during the forecast period.

The Asia Pacific vaccines market is expected to reach US$ xx Million in 2028 from US$ 7,254.5 Million in 2020. The market is estimated to grow with a CAGR of 6.4% from 2020-2028.

Market Dynamics

Market Growth Drivers Analysis

Rising awareness of vaccination benefits in emerging markets is further expected to foster the vaccine market growth in APAC. Consumer affordability growth, especially in emerging markets, will drive vaccine market sales, especially for self-payed (Category II) vaccines. Inactivated vaccines are expected to dominate the market owing to its benefits, including a long-shelf life and high stability. DNA vaccines are expected grow fast, mainly due to high specificity and reduced risk of genome integration as compared to traditional vaccines. High number of promising compounds in the vaccine pipeline. Vaccines in Phase III clinical trials include fatal diseases like HIV/AIDS and malaria.

Market Restraints

Limited awareness of infectious diseases and prevention, especially in emerging markets. Limited physician and hospital accessibility in emerging markets constrains access to vaccines. Continued trust in public and private vaccine systems is critical. China’s 2018 vaccine contamination / quality issues triggered a flight to quality with a push by parents for more Australian vaccines. Individuals are still unconvinced that vaccine offers protection or that it is safe. Mismatch in perception between price and value.

Competitive Landscape

Key Players

Some of the major primary and secondary sources for vaccines included in the report are Immunization Partners in Asia Pacific (IPAP), Food and Drug Administration, World Health Organization, National Polio Surveillance Project (NPSP), Global Alliance for Vaccines and Immunization (GAVI) and Others.

  • PFIZER INC
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Panacea Biotic Limited

Products in Pipeline

Across all disease areas, 214 vaccines are in various phases of development. Top three disease areas with candidate products are HIV/AIDS (40), malaria (32) and pneumococcal infections (27). There are 20 vaccines in Phase-III development stage, with most phase-III products for pneumococcal infections and rabies.

Notable Recent Deals

  • For instance, India, along with other WHO South East Asia Region member countries, has initiated a campaign to eradicate measles and control rubella/congenital rubella syndrome (CRS) by 2020.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

In more developed APAC countries, government focus on vaccinations has increased coverage of strains on national immunization programs. In developing APAC countries, the GAVI Alliance contributed to the funding of immunization. The campaigns by the Ministry of Health & Family Welfare aims to immunize 41 crore children in India. The first phase of the campaign was successfully completed in February 2017 in five states, namely, Tamil Nadu, Karnataka, Goa, Lakshadweep, and Puducherry. Over 3.3 crore children were vaccinated, reaching out to 97% of the targeted age group. The campaign was conducted in schools, community centers, and other health facilities. There are several vaccination programs, campaigns, conferences, being held in the Asia Pacific region in order to raise awareness among the population.

1. Report Description of the APAC Vaccines Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Vaccines Market Analysis Executive Summary
2.1 APAC Vaccines Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Vaccines Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Improving immunization awareness
3.1.2 Rise in consumer affordability
3.1.3 Emergence of innovative vaccine types
3.1.4 New vaccines for fatal diseases
3.2 Market Restraints Analysis
3.2.1 Lack of awareness
3.2.2 Inadequate delivery infrastructure
3.2.3 Consumer trust and confidence
3.2.4 Perception of limited value
4. APAC Vaccines Market Segmentation
4.1 By Technology:
4.1.1 Recombinant Vaccines
4.1.2 Conjugate Vaccines
4.1.3 Live Attenuated Vaccines
4.1.4 Inactivated Vaccines
4.1.5 Toxoid Vaccines
4.2 By Disease Indication:
4.2.1 DTP (Diphtheria, Tetanus, And Pertussis)
4.2.2 Influenza
4.2.3 Hepatitis
4.2.4 Others
4.3 By Route of Administration:
4.3.1 Oral Market
4.3.2 Injectable Market
4.3.3 Others
4.4 By Patient Type:
4.4.1 Paediatric Market
4.4.2 Adults Market
5. APAC Vaccines Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Vaccine Market
6.4 Notable recent deals in Vaccine Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.2 GlaxoSmithKline Plc. Company overview
Product & Services, Strategies & Financials
7.3 Merck & Co., Inc. Company overview
Product & Services, Strategies & Financials
7.4 Sanofi Company overview
Product & Services, Strategies & Financials
7.5 Johnson & Johnson Services, Inc. Company overview
Product & Services, Strategies & Financials
7.6 Panacea Biotic Limited Company overview
Product & Services, Strategies & Financials
7.7 Astellas Pharma Inc. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Vaccines market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Vaccines Market Analysis Segmentation

By Technology:

Attenuated virus or bacterium used as a vector for an immunogenic protein from another infectious agent. In 2018, the conjugate vaccines segment held the largest market share of 27.2% of the vaccines market, by type. This segment is also expected to dominate the market in 2027 owing to the advantages offered by the vaccines for diseases such as pneumonia and others. Furthermore, the conjugate vaccines segment is anticipated to witness the significant growth rate during the forecast period, 2020 to 2028.

By Disease Indication:

Asia Pacific vaccines market by the disease indication was led by the other segments, which has included diseases such as poliomyelitis (polio), measles, mumps, rubella, pneumococcal infections, and others. The others segment has the largest market share in 2018, which accounted for 59.6% and is expected to dominate the market in 2028.

By Route of Administration:

The vaccines market by the route of administration was led by the injectable segment.

By Patient Type:

The market of the vaccines in the Asia Pacific by the patient type was led by the paediatric segment.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements